EDMONTON, March 12, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced
that the Company, effective Monday March 19,
2018, will be added to the S&P/TSX Composite Index, the
primary gauge for Canadian-based, Toronto Stock Exchange listed
companies.
The S&P/TSX Composite Index consists of the largest Canadian
companies by market capitalization and liquidity. Inclusion in the
index broadens a company's addressable institutional investor
universe, including index tracker funds and similar vehicles.
"Inclusion in the index just over two years after commencing
commercial operations is a reflection of our exceptional pace of
growth and shareholder value creation, and a testament to the
Aurora Standard, which represents excellence in execution and
customer care," said Terry Booth,
CEO. "This latest milestone will further expand our retail and
institutional investor audience and further enhance Aurora's
liquidity, as we continue to execute diligently on our global
expansion strategy."
For more information on the S&P/TSX Composite Index go to
https://ca.spindices.com/indices/equity/sp-tsx-composite-index
Director Resignation
Aurora also announced today that Joseph del Moral has resigned
his position as Director of the Company to pursue a non-cannabis
related opportunity. Mr. del Moral, who also resigned from his
position as CEO of CanvasRx, will continue to assist both Aurora
and CanvasRx during a transitionary period, and will remain
available to the Company as an advisor.
"We are sad to see Joseph leave but are grateful for the
important role he has played in the development of Aurora, and are
pleased that he has agreed to continue supporting Aurora as an
advisor," said Terry Booth. "We wish
Joseph great success with his new venture."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", and a second 40,000 square foot high-technology
production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island. In January 2018, Aurora's 800,000 square foot
flagship cultivation facility, Aurora Sky, located at the
Edmonton International Airport,
was licensed. Once at full capacity, Aurora Sky is expected to
produce over 100,000 kg per annum of cannabis. Aurora is
completing a fourth facility in Lachute,
Quebec utilizing its wholly owned subsidiary Aurora Larssen
Projects Ltd.
Aurora also owns Berlin-based
Pedanios, the leading wholesale importer, exporter, and distributor
of medical cannabis in the European Union. The Company owns 51% of
Aurora Nordic, which will be constructing a 1,000,000 square foot
hybrid greenhouse in Odense,
Denmark. The Company offers further differentiation through
its acquisition of BC Northern Lights Ltd. and Urban Cultivator
Inc., industry leaders, respectively, in the production and sale of
proprietary systems for the safe, efficient and high-yield indoor
cultivation of cannabis, and in state-of-the-art indoor gardening
appliances for the cultivation of organic microgreens, vegetables
and herbs in home and professional kitchens.
Aurora holds a 19.88% ownership interest in Liquor Stores N.A.,
who intend to develop a cannabis retail network in Western Canada. In addition, the Company holds
approximately 17.23% of the issued shares in leading extraction
technology company Radient Technologies Inc., and has a strategic
investment in Hempco Food and Fiber Inc., with options to increase
ownership stake to over 50%. Aurora is also the cornerstone
investor in two other licensed producers, with a 22.9% stake in
Cann Group Limited, the first Australian company licensed to
conduct research on and cultivate medical cannabis, and a 17.62%
stake in Canadian producer The Green Organic Dutchman Ltd., with
options to increase to majority ownership.
Aurora's Common Shares trade on the TSX under the symbol
"ACB".
On behalf of the Boards of
Directors,
AURORA CANNABIS
INC.
Terry
Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.